(Q38161412)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24213625%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Advances in the pathogenesis and treatment of systemic juvenile idiopathic arthritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24213625%20AND%20SRC:MED&resulttype=core&format=json

juvenile rheumatoid arthritis

29 February 2020

main subject

pathogenesis

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24213625%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Bryce A. Binstadt

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24213625%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

2

Bryce A Binstadt

1 reference

30 August 2017

Colleen K Correll

1

1 reference

30 August 2017

language of work or name

English

0 references

publication date

8 November 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24213625%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24213625%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

75

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24213625%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24213625%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

176-183

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24213625%20AND%20SRC:MED&resulttype=core&format=json

Clinico-immunological profile in juvenile rheumatoid arthritis--an Indian experience

29 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Predictors of disease course and remission in systemic juvenile idiopathic arthritis: significance of early clinical and laboratory features

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Subtype-specific peripheral blood gene expression profiles in recent-onset juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Mutations of the hemophagocytic lymphohistiocytosis-associated gene UNC13D in a patient with systemic juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Experience with hemophagocytic lymphohistiocytosis/macrophage activation syndrome at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Macrophage activation syndrome: serological markers and treatment with anti-thymocyte globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Efficacy and safety profile of cyclosporin A in the treatment of juvenile chronic (idiopathic) arthritis. Results of a 10-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Thalidomide for severe systemic onset juvenile rheumatoid arthritis: A multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Clinical remission in patients with systemic juvenile idiopathic arthritis treated with anti-tumor necrosis factor agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Juvenile idiopathic arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

A randomized controlled trial of calcium supplementation to increase bone mineral density in children with juvenile rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Long-term follow-up of autologous stem cell transplantation for refractory juvenile idiopathic arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Autologous T cell depleted haematopoietic stem cell transplantation in children with severe juvenile idiopathic arthritis in the UK (2000-2007).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Profile of Indian patients with juvenile onset chronic inflammatory joint disease using the ILAR classification criteria for JIA: a community-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Prognostic indicators of joint destruction in systemic-onset juvenile rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Specific gene expression profiles in systemic juvenile idiopathic arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Effect of IL-6 on IGF binding protein-3: a study in IL-6 transgenic mice and in patients with systemic juvenile idiopathic arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Rapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Preliminary definition of improvement in juvenile arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

IL-1 Trap rilonacept in refractory adult onset Still's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Combination therapy of abatacept and anakinra in children with refractory systemic juvenile idiopathic arthritis: a retrospective case series

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187

Clinical analysis of 570 cases with juvenile rheumatoid arthritis: results of a nationwide retrospective survey in Japan.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.187